The launch of the Retatru vial marks a significant advance in the approach to weight regulation. This groundbreaking therapy combines two distinct mechanisms – stimulation of the GLP-1 receptor and blocking of the DPP-4 enzyme – suggesting a different method for managing weight concerns. Early clinical findings demonstrate substantial efficacy